admission date:  [2100-12-29]              discharge date:   [2101-1-7]service: medicineallergies:norvasc / cipro i.v.attending:[first name3 (lf) 13541]chief complaint:hypotensionmajor surgical or invasive procedure:picc line placementhistory of present illness:mr. [known lastname 22236] is an 89 y.o. m with systolic chf (ef 45% in [9-25]),s/p mca cva, afib, htn, and dm ii, recently admitted to [hospital1 18]from [date range (1) 8945] and [date range (1) 22237] for hap and uti [last name (un) ] transferredfrom [hospital ] hosp for hypotension.history is unclear as obtained from scant osh records andpatient unable to give history. he appears to have been at nhwhen found to sats 81% ra, foley draining dark amber urine. hewas noted to have severe peripheral edema and given levoquin x 1and lasix 40 mg iv x 1 at osh. he became hypotensive to 80's atosh, placed an ej and started peripheral neo.in the ed, initial vs were: t 100, p 81, bp 107/58, r 18, 100%nrb o2 sat. patient was given vanc/zosyn, tylenol, and 1l ns ined. bladder was changed in ed with ucx very positive and sent toicu.on the floor, he has no complaints. history is obtained mostlyfrom son as patient only answers with single words.past medical history:l mca stroke with right-sided hemiparesis, aphasia [12/2090]systolic chf with ef 45-50% in [9-/2100]mild pulmonary artery hypertensionatrial fibrillation with slow ventricular responseheart block s/p [company 1543] sensia single-chamber pacemaker [3-25]benign hypertensionhyperlipidemiatype 2 diabetesrle cellulitisrle dvt (on coumadin)s/p ivc filter [10/2099]sleep apnea (intolerant of cpap)bladder diverticulum w/ ? fungal infection, currently inoperableper most recent urology note followed by [first name8 (namepattern2) ] [last name (namepattern1) 770]recurrent utissocial history:he does not drink or smoke. widower with 3 children. formerpro-baseball scout for numerous pro-teams. was one of the firstscouts to recruit a minority player (to philly), and was thenblack-listed for this reason for 5 years. he coached for manymany years at [location (un) 5871] college, where he boasted a 100%graduation rate. lives in a nursing home, and is visited dailyby his sons, who performs many of the tasks of daily care. hedoes not drink, smoke, nor use recereational drugs. widower with3 children.family history:non-contributoryphysical exam:vitals: tm/c 97.8, 80s, 100-120s/50-60s, 98% on rageneral: sleepy, appears comfortable, responds to a fewquestions, oriented to [state 350] & baseball.  doescommunicate often appropriately.heent: pupils small b/l, but reactive to light. scleraanicteric, mmm, oropharynx clearneck: supple, jvp not elevated, no ladlungs: clear to auscultation bilaterally, diffuse wheezes,rales, ronchicv: regular rate and rhythm, normal s1 + s2, no murmurs, rubs,gallopsabdomen: somewhat firm, non-tender, non-distended, bowel soundspresent, no rebound tenderness or guarding, no organomegalyext: warm, well perfused, 2+ pulses, no clubbing, cyanosis oredema, multipodus boots on.skin: few crusted ulcers on toesgu: swollen scotumpertinent results:discharge labs:[2101-1-6] 06:23am blood wbc-12.3 rbc-2.62 hgb-8.4 hct-25.2mcv-96 mch-31.9 mchc-33.2 rdw-15.9 plt ct-281[2101-1-6] 07:00am blood pt-28.7 ptt-42.2 inr(pt)-2.9[2101-1-6] 06:23am blood glucose-68 urean-15 creat-1.4 na-145k-3.7 cl-113 hco3-25 angap-11[2101-1-6] 06:23am blood calcium-6.7 phos-2.7 mg-1.7[2100-12-28] 11:00pm blood vitb12-1170 folate-6.5[2101-1-5] 07:57pm blood tobra-1.2imaging:[1-3] cxr:there is increased hazy vasculature bilaterally with bilateralpleural effusions, left greater than right that have increased.compared to the prior study, there is dense retrocardiacopacification consistent with volume loss/effusion/infiltrate.compared to the prior study, the amount of pulmonary edema hasincreased. an underlying infectious infiltrate particularly onthe left cannot be totally excluded.[12-28] scrotal u/s:significant subcutaneous scrotal swelling with nohypervascularity and no gas within the tissues identified. thisedema may be due to third spacing but ultrasound is unable tofurther characterize. a clinical evaluation is recommended toexclude a subcutaneous infectiousprocess, and if further imaging is required, a ct could beperformed.2) no evidence of an intratesticular mass. no evidence ofepididymitis ororchitis.microbiology:final report [2101-1-1]   urine culture (final [2101-1-1]):      pseudomonas aeruginosa.    >100,000 organisms/ml..      escherichia coli.    >100,000 organisms/ml..                              sensitivities: mic expressed inmcg/ml_________________________________________________________                             pseudomonas aeruginosa                             |          escherichia coli                             |          |ampicillin------------             =>32 rampicillin/sulbactam--                4 scefazolin-------------               32 rcefepime--------------     8 s      <=1 sceftazidime-----------     4 s      <=1 sceftriaxone-----------              <=1 scefuroxime------------               16 iciprofloxacin---------   =>4 r      =>4 rgentamicin------------     2 s      <=1 smeropenem-------------  =>16 r   <=0.25 snitrofurantoin--------             <=16 spiperacillin----------    16 s    =>128 rpiperacillin/tazo-----    16 s      <=4 stobramycin------------   <=1 s      <=1 strimethoprim/sulfa----              <=1 sfinal report [2101-1-3]   blood culture, routine (final [2101-1-3]):    no growth.[2101-1-4] 6:32 am blood culture      source: line-picc 2 of 2.   blood culture, routine (pending):brief hospital course:an 89 year old gentleman with systolic chf, chronic foley whopresented from rehab with psuedomonal/e. coli urosepsis.#) urosepsis:  the patient was admitted to the micu formanagement of urosepsis.  while there he was maintained onneosynephrine for 2 days.  he was started on vancomycin & zosyn. the patient was called out to the floor on zosyn & tobramycin.further microbiologic data suggested a treatment change totobramycin & ceftazidime to be continued until [2101-1-12].throughout this admission the patient's chronic foley due tobladder diverticulum remained in place and regularly irrigated.-ceftazidime 2g iv q12h last dose [2101-1-12]-tobramycin 100mg iv q24, decrease dose to 80mg on [2101-1-9] tofinish course on [2101-1-12].-foley requires hand irrigation q4-6 hours, no continuousbladder irrigation.#) atrial fibrillation:  the patient has a history of atrialfibrillation for which he is on chronic anti-coagulation andmetoprolol.  due to his poor po intake and self-sustained ratecontrol, the patient will not be continued on metoprolol.  hiscoumadin was held for much of his admission given asupratherapeutic inr.  he will be discharged on 2mg daily withpt levels to be followed twice weekly, goal [12-21].#) chronic dvts: anticoagulated as above.#) malnutrition/wound care (sacral decubitus & leg ulcers):  thepatient is tolerating limited po with siginificant aspirationrisk & aspiration events.  other feeding options were discussedwith the family but they have opted to maintain oral feeding.of note, the patient has a low albumin in the 1s withsignificant wound care issues as well as significant scrotaledema.  the patient was admitted on zinc, vitamin c, & vitamin bbut due to his poor ability to consume pills these medicineshave not been continued.#) leukocytosis: the patient has had a maintained elevated whiteblood cell count while admitted. this is likely due to hisongoing pseudomonal uti/chronic foley.  an assay for c. diff wassent off and the results will be called to the acceptingfacility.- if c. diff positive, will begin flagyl 500mg iv q8 at thediscretion of the family.#) chf: the patient has a history of congestive heart failure.given his renal failure and hypotension his lasix was initiallyheld. given his tenuous renal failure we have not restartedlasix on discharge.#) pain: the patient was maintained on a fentanyl patch and withtylenol and morphine iv.  on discharge he will be transitionedto sublingual or liquid morphine for pain control.# arf: the patient has persistent renal failure with baselinecreatinine 0.8, 1. on discharge. all medicines were renallydosed.# hypertension:  the patient's beta blocker and ace inhibitorwere not continued.# type 2 diabetes:  the patient was continued on an insulinsliding scale but did not require insulin.  we recommendreducing his finger sticks to once daily only.# anemia: the patient had fluctuating blood volume without clearblood loss other than phlebotomy.  he was not transfused on thisadmission.# l heel stage ii pressure ulcer: wound care as above.# dementia:  the patient has chronic dementia.  he was unable toreliably take food by mouth, however in accordance with thefamily wishes he was fed but kept on aspiration precautions.medications on admission:medications:1. fentanyl 12 mcg/hr patch 72 hr [month/day (3) ]: one (1) patch 72 hrtransdermal q72h (every 72 hours).2. allopurinol 100 mg tablet [month/day (3) ]: one (1) tablet po daily(daily).3. lansoprazole 30 mg tablet,rapid dissolve, dr [last name (stitle) ]: one (1)tablet,rapid dissolve, dr [last name (stitle) ] daily (daily).4. metoprolol tartrate 25 mg tablet [last name (stitle) ]: 0.5 tablet po bid (2times a day).5. multivitamin,tx-minerals tablet [last name (stitle) ]: one (1) tablet podaily (daily).6. paroxetine hcl 10 mg tablet [last name (stitle) ]: one (1) tablet po daily(daily).7. lisinopril 5 mg tablet [last name (stitle) ]: one (1) tablet po daily (daily).8. chlorhexidine gluconate 0.12 % mouthwash [last name (stitle) ]: one (1) mlmucous membrane qid (4 times a day).9. furosemide 20 mg tablet [last name (stitle) ]: one (1) tablet po daily (daily).10. zinc sulfate 220 mg capsule [last name (stitle) ]: one (1) capsule po daily(daily) for 4 days.11. vitamin a 10,000 unit capsule [last name (stitle) ]: two (2) capsule po daily(daily) for 4 doses.12. ascorbic acid 500 mg tablet [last name (stitle) ]: one (1) tablet po once aday for 4 days.13. coumadin 1 mg tablet [last name (stitle) ]: one (1) tablet po once a day:target inr [12-21]. inr on [12-16] was 3.9, so hold dose on [12-16] andrecheck.14. insulin lispro 100 unit/ml solution [month/year (2) ]: qachs per slidingscale subcutaneous asdir (as directed).15. polyvinyl alcohol-povidone 1.4-0.6 % dropperette [month/year (2) ]: [11-19]drops ophthalmic [hospital1 ] (2 times a day).16. oxybutynin chloride 5 mg tablet [hospital1 ]: one (1) tablet po tid(3 times a day).17. metronidazole 500 mg tablet [hospital1 ]: one (1) tablet po q8h(every 8 hours) for 2 weeks.18. acetaminophen 325 mg tablet [hospital1 ]: 1-2 tablets po q6h (every 6hours) as needed for pain.discharge medications:1. bisacodyl 5 mg tablet, delayed release (e.c.) [hospital1 ]: two (2)tablet, delayed release (e.c.) po daily (daily) as needed.2. senna 8.6 mg tablet [hospital1 ]: one (1) tablet po bid (2 times aday) as needed.3. fentanyl 12 mcg/hr patch 72 hr [hospital1 ]: one (1) patch 72 hrtransdermal q72h (every 72 hours).4. bacitracin zinc 500 unit/g ointment [hospital1 ]: one (1) appl topicalqid (4 times a day).5. miconazole nitrate 2 % powder [hospital1 ]: one (1) appl topical tid(3 times a day).6. acetaminophen 500 mg/5 ml liquid [hospital1 ]: one (1)  po q6h (every6 hours): please mix with patient's pre-thickened water.patient may refuse.7. sodium chloride 0.9%  flush 10 ml iv prn line flushpicc, non-heparin dependent: flush with 10 ml normal salinedaily and prn per lumen.8. ceftazidime 2 gram recon soln [hospital1 ]: one (1) recon solninjection q12h (every 12 hours) for 5 days: last dose [2101-1-12].9. tobramycin sulfate 40 mg/ml solution [year (4 digits) ]: 2.5 ml injectionq24h (every 24 hours) for 5 days: [1-7] to [1-8]: 100mg q24hchange of dose:[1-10] to [1-12]: 80mg q24.10. morphine sulfate 5 mg/0.25 ml solution [month/year (2) ]: ten (10) mgsublingual every four (4) hours as needed for pain.11. lansoprazole 30 mg tablet,rapid dissolve, dr [last name (stitle) ]: one (1)tablet,rapid dissolve, dr [last name (stitle) ] once a day.12. polyvinyl alcohol-povidone 1.4-0.6 % drops [last name (stitle) ]: one (1) gttophthalmic twice a day.13. warfarin 2 mg tablet [last name (stitle) ]: one (1) tablet po once a day:please check pt twice weekly and titrate accordingly to goal inr[12-21].14. insulin lispro 100 unit/ml solution [month/day (3) ]: asdir  subcutaneousonce a day: please check finger sticks qam and follow slidingscale as directed.discharge disposition:extended carefacility:[location (un) 582] of [location (un) 5176]discharge diagnosis:1. sepsis due to bacterial uti (pseudomonas and e.coli)2. acute on chronic systolic heart failure3. acute renal failure4. severe malnutrition with albumin <1.55. stage ii decubitus ulcers6. history of dvt status post ivc filter, on coumadin7. atrial fibrillation8. dementia9. bladder diverticulum with chronic indwelling foley catheterdischarge condition:vital signs stable, chronically ill.discharge instructions:you have been admitted to the hospital with a serious urinaryinfection.  while you were here you were cared for in theintensive care unit and on the medical wards.  you will bedischarged on iv antibiotics for this infection.please take all medicines as directed as they have changed.  wehave stopped many of your medicines so please check carfeully.followup instructions:mr. [known lastname 22236] has the following appointment already scheduledprior to this admission.provider:  [name10 (nameis) 676] clinic phone:[telephone/fax (1) 62] date/time:[2101-1-21]4:00dr.[name (ni) ] will be following mr. [known lastname 22236] after discharge.he can be reached at [telephone/fax (1) 22235]                             [first name8 (namepattern2) ] [last name (namepattern1) ] md [md number(2) 13546]